2020 Citations

Publications mentioning the use of Reddot Biotech products from 2020:

1. Cambria, E., Arlt, M. J., Wandel, S., Krupkova, O., Hitzl, W., Passini, F. S., ... & Wuertz-Kozak, K. (2020). TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells. Cells, 9(7), 1736.

https://www.mdpi.com/2073-4409/9/7/1736

Products mentioned: RD-PGE2-Ge

2.Rehman, H., Jahan, S., Ullah, I., Thörnqvist, P., Jabbar, M., Shoaib, M., . . . John, N. (2020). Effects of endocrine disruptor furan on reproductive physiology of sprague dawley rats: An F1 extended one-generation reproductive toxicity study (EOGRTS). Human & Experimental Toxicology, , 96032712091141.

https://doi.org/10.1177/0960327120911416

Products mentioned: RD-FSH-Ra, RD-LH-Ra

3. Magkouta, S. F., Pappas, A. G., Vaitsi, P. C., Agioutantis, P. C., Pateras, I. S., Moschos, C. A., ... & Kalomenidis, I. T. (2020). MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage. JCI insight, 5(12).

https://doi.org/10.1172/jci.insight.134885

Products mentioned: RDR-8-OHdG-Ge

The list is updated frequently, so be sure to check back soon to see new additions!

Questions or comments? Contact us here.